Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 1 day ago
Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the company or Viridian), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare...
Share to Feed
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced it will host...
Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the company or Viridian), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare...
VIRIDIAN SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Viridian Therapeutics, Inc. (VRDN) and Encourages Investors to Contact the Firm VIRIDIAN SHAREHOLDER ALERT: Kaskela Law LLC...
For the last three days, A.I.dvisor has detected that VRDN's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
This is a Bearish indicator signaling VRDN's price could decline from here. Traders may explore shorting the stock or put options...
Viridian Therapeutics, Inc. (NASDAQ:VRDN Get Free Report)s share price fell 4.7% during mid-day trading on Friday after B. Riley lowered their price target on the stock from $29.00 to...
This is a Bullish indicator signaling VRDN's price could rise from here. Traders may explore going long the stock or buying call options...
Viridian Therapeutics (NASDAQ:VRDN Get Free Report)s stock had its buy rating reaffirmed by analysts at Needham Company LLC in a note issued to investors on...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...